ARCHIVES

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

This article is from The Cancer Letter archive.

Vol. 22 No. 14 | April 4, 1996

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002

Move to Boycott Cancer Congress Gains Some Support

January 20, 1978

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004